iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
A Multicenter Compassionate Use Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C - Europe
  Verified April 2014 by Bristol-Myers Squibb


NHS England agrees funding for life-saving hepatitis C drug(s) sofosbuvir, daclatasvir - (06/09/14)
Scotland.....Hepatitis C drug is approved.... - (06/11/14)
  iconpaperstack View Older Articles   Back to Top   www.natap.org